Stem Pharm has been awarded an SBIR Advance grant to aid our technology commercialization efforts by the Wisconsin Economic Development Corporation (WEDC) and the University of Wisconsin-Extension’s Center for Technology Commercialization (CTC). https://wisconsinsbir.org/content/state-matching-grants-boost-six-high-tech-small-businesses
Stem Pharm hydrogel technologies are the focus of a recently published manuscript, "Versatile synthetic alternatives to Matrigel for vascular toxicity screening and stem cell expansion" published in Nature Biomedical Engineering with an accompanying 'story behind the paper' written by Eric Nguyen. https://www.nature.com/articles/s41551-017-0096 https://nbmecommunity.nature.com/channels/541-behind-the-paper
Stem Pharm has been awarded a $291,000 Phase I SBIR grant from the National Center For Advancing Translational Sciences of the National Institutes of Health. http://news.wisc.edu/spinoff-harnesses-stem-cells-for-new-medical-uses/
Feature on our hydrogel technologies, "Advance furthers stem cells for use in drug discovery, cell therapy" by David Tenenbaum https://medicalxpress.com/news/2017-07-advance-furthers-stem-cells-drug.html
Stem Pharm feature on Xconomy. http://www.xconomy.com/wisconsin/2017/05/18/stem-pharm-aims-to-add-to-madisons-stem-cell-past-with-biomaterials/
Stem Pharm's interaction with the University of Wisconsin Biotechnology Training Program is featured in this article: https://btp.wisc.edu/2017/09/12/three-decades-of-btp-scientists-intersect-at-madison-stem-cell-startup/
Stem Pharm's Jeff Nelson, Ph.D. will be presenting a poster entitled "Designed Biomaterials for Assay Development and Organoid Culture" at the Keystone Symposia’s Organs- and Tissues-on-Chips Conference on April 8-12, 2018 in Big Sky, MT (http://www.keystonesymposia.org/index.cfm?e=web.Meeting.Program&meetingid=1514).
Stem Pharm will be attending the 57th Annual Society of Toxicology (SOT) Meeting and ToxExpo at the Henry B. González Convention Center in San Antonio, Texas (March 11-15, 2018; https://www.toxicology.org/events/am/am2018/). If you would like to meet with us please contact us through our contact portal.
Stem Pharm will be attending the High-Content Analysis & 3D Screening Conference (November 6-8, 2017 in Cambridge, MA). If you would like to meet with us at either of these meetings, please contact us through our contact portal. For your convenience, here is the link to the meeting. http://www.highcontentanalysis.com/
Stem Pharm presented at the 3D CNS Disease Modeling Workshop sponsored by the National Institute of Health on November 11, 2016. https://www.ninds.nih.gov/News-Events/Events/3D-CNS-Disease-Modeling-Workshop
Stem Pharm was a finalist at Thermo Fisher Scientific's 2016 Innovation Day on October 12, 2016 https://www.thermofisher.com/us/en/home/about-us/events/life-science/innovation-day-2016.html